Saudi Journal of Gastroenterology

IN FOCUS
Year
: 2007  |  Volume : 13  |  Issue : 3  |  Page : 147--149

Fibroscan® : A noninvasive test of liver fibrosis assessment


Abdullah S Al-Ghamdi 
 Gastroenterology Division, Medical Department, King Fahad General Hospital, PO Box 50564, Jeddah 21533, Saudi Arabia

Correspondence Address:
Abdullah S Al-Ghamdi
Gastroenterology Division, Medical Department, King Fahad General Hospital, PO Box 50564, Jeddah 21533
Saudi Arabia

Determination of the extent of progress of hepatic fibrosis is important in clinical practice, where it may reflect the severity of liver disease and predict response to treatment. Percutaneous liver biopsy is the gold standard for grading and staging of liver disease. However, liver biopsy is an invasive procedure with certain unavoidable risks and complications. Several methods have been studied in an attempt to reach a diagnosis of cirrhosis by noninvasive means. Fibroscan® has been designed to quantify liver fibrosis by means of elastography and found to have reasonably good sensitivity and specificity patterns, especially in patients with advanced fibrosis and can be used as an alternative to liver biopsy.


How to cite this article:
Al-Ghamdi AS. Fibroscan® : A noninvasive test of liver fibrosis assessment.Saudi J Gastroenterol 2007;13:147-149


How to cite this URL:
Al-Ghamdi AS. Fibroscan® : A noninvasive test of liver fibrosis assessment. Saudi J Gastroenterol [serial online] 2007 [cited 2020 Oct 20 ];13:147-149
Available from: https://www.saudijgastro.com/article.asp?issn=1319-3767;year=2007;volume=13;issue=3;spage=147;epage=149;aulast=Al-Ghamdi;type=0